We have successfully completed the Market Engagement stage of our Interactium® data platform development, with responses received from 32 providers. This stage played a critical role in gathering insights, understanding supplier capabilities and ensuring our requirements are clearly aligned with the current market offerings. This preparatory step helps to inform and refine our requirements before the formal tendering process for the Interactium® data platform development begins.
The Interactium® is a global, patient-centric data platform that integrates clinical, wearable, and self-reported data to provide a comprehensive view of each patient, supporting better treatment development, healthcare decisions, and personalised feedback. Find out more about the Interactium® here.
The next stage for the Interactium® data platform development includes preparing for the formal release of the Request for Proposal (RFP) which will be publicly available and open to responses. This stage will support us to ultimately select the best vendor positioned to deliver on our goals. This decision will be based on an assessment and scoring system designed to ensure fairness, objectivity and alignment with our strategic goals.
We look forward to sharing further updates as the process advances.
